Search results for "Highlights"


 
Results 141 - 150 of about 248 for "Highlights".
Sort by: Relevance | Newest | Oldest

More frequent bowel movements may be associated with diverticulitis risk

An analysis of participants in the Nurses' Health Study and the Health Professionals Follow-up Study found that more frequent bowel movements appear to be a risk factor for subsequent diverticulitis in both men and women.
https://gastroenterology.acponline.org/archives/2021/01/22/2.htm
22 Jan 2021

Q&A: A deeper dive into ACP's new diverticulitis guidelines

Authors discussed the College's first clinical guidelines on diagnosis and management of diverticulitis, which provide recommendations on when to use imaging, antibiotics, colonoscopy, and other interventions.
https://gastroenterology.acponline.org/archives/2022/01/28/1.htm
28 Jan 2022

ACG guideline updates recommendations on diagnosis, management of GERD

Proton-pump inhibitors remain a standard treatment for gastroesophageal reflux disease (GERD) despite increased scrutiny of side effects, although new treatments are emerging, the guideline from the American College of Gastroenterology (ACG) stated.
https://gastroenterology.acponline.org/archives/2021/12/17/1.htm
17 Dec 2021

Systematic review compares over-the-counter treatments for chronic constipation

Polyethylene glycol and senna had good evidence for their use as first-line laxatives, while moderate evidence supported fiber supplements, fruits, stimulant laxatives, and magnesium-based products.
https://gastroenterology.acponline.org/archives/2021/06/25/3.htm
25 Jun 2021

Rivaroxaban associated with increased risk for GI bleeding compared to other DOACs

A study in Iceland of direct oral anticoagulants (DOACs) found a higher risk for overall and major GI bleeding with rivaroxaban than with either apixaban or dabigatran.
https://gastroenterology.acponline.org/archives/2021/10/22/1.htm
22 Oct 2021

Guidance offered for managing colorectal dysplasia in patients with IBD

Among other best practice advice from the American Gastroenterological Association, precancerous colorectal lesions in patients with inflammatory bowel disease (IBD) should be described as polypoid, nonpolypoid, or invisible using a modified Paris Classification.
https://gastroenterology.acponline.org/archives/2021/09/24/1.htm
24 Sep 2021

Infliximab or tofacitinib for IBD associated with lower response to COVID-19 vaccination

An industry-funded study in England looked at SARS-CoV-2 antibody concentrations after two vaccine doses among patients taking infliximab, tofacitinib, thiopurine, ustekinumab, or vedolizumab for inflammatory bowel disease (IBD), comparing them to healthy controls.
https://gastroenterology.acponline.org/archives/2022/02/25/1.htm
25 Feb 2022

Spotlight on The Liver Meeting

Highlights from the American Association for the Study of Liver Diseases' annual meeting, held virtually this past weekend, included insights on COVID-19 and the liver and a conversation with the winners of the Nobel Prize in Physiology or Medicine 2020, who discovered hepatitis C virus.
https://gastroenterology.acponline.org/archives/2020/11/20/5.htm
20 Nov 2020

Dietary choices, some drugs may reduce incidence of colorectal cancer

While NSAIDs and a high consumption of fruits and vegetables were associated with a decreased incidence of colorectal cancer, frequent consumption of alcohol or meat was linked to increased colorectal cancer incidence, a systematic review found.
https://gastroenterology.acponline.org/archives/2020/10/23/2.htm
23 Oct 2020

CDC updates guidance on responding to health care exposures to HCV

The CDC called for hepatitis C virus (HCV) testing of both the patient and exposed personnel as soon as possible after an exposure incident, preferably within 48 hours.
https://gastroenterology.acponline.org/archives/2020/08/28/2.htm
28 Aug 2020

Result Page: Prev   10   11   12   13   14   15   16   17   18   19   Next